The event, presented by the Maryland Stem Cell Research Fund (MSCRF) in collaboration with the Maryland Department of Commerce, will spotlight the latest advancements in stem cell research and regenerative medicine technology. Attendees will have the opportunity to listen to elevator pitches from MSCRF's portfolio companies and academic researchers, each showcasing their unique value proposition. Additionally, the Showcase will include poster presentations highlighting promising technologies, fostering engagement and dialogue.
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) at the FDA, will serve as a keynote speaker, offering insights and guidance for expediting the approval of regenerative medicine-based products.
The event will conclude with a happy hour and networking session, allowing companies, investors, entrepreneurs, startups, and other stakeholders in the stem cell research field to connect and explore investment and collaboration opportunities within the ecosystem.
MSCRF's primary objective is to facilitate meaningful connections for its awardees, thereby strengthening the Maryland ecosystem and advancing stem cell research to improve patient outcomes. It's important to note that MSCRF does not endorse any specific company to potential funders or engage in deal-making negotiations resulting from connections made at the event.
